Skip to main content
. 2019 Jan 8;19:11. doi: 10.1186/s12886-018-1012-y

Table 1.

Baseline Demographics and Patient Characteristics Assessed for Predictive Value of Early Visual Acuity Outcomes

Baseline predictors of early achievement of BCVA 20/40 or better (Snellen equivalent)
 BCVA (≤ 50, >  50)
 Subretinal fluid
 Total macular volume (≤ 9.99 mm3, >  9.99 mm3)
Baseline predictors of early first BCVA gain of 15 or more ETDRS letters
 Sex
Variables that did not have a predictive value on visual outcomes
 Age (≤ 60 years, >  60 years)
 Race
 BMI (<  30 kg/m2, ≥ 30 kg/m2)
 Disease type (BRVO/HRVO vs CRVO)
 Months since RVO diagnosis
 Smoking status
 Hypertension
 Diabetes
 Prior RVO therapies		 Central subfield thickness (≤ 400 μm,
>  400 μm)
Edema
Cystoid space
Retinal hemorrhage
Diffuse edema
BCVA (≤ 35, 35–50, >  50 ETDRS letters)
Treatment group
DBP (<  80 mmHg, ≥ 80 mmHg)
SBP (<  140 mmHg, ≥ 140 mmHg)

BCVA best-corrected visual acuity, BMI body mass index, BRVO branch retinal vein occlusion, CRVO central retinal vein occlusion, DBP diastolic blood pressure, ETDRS Early Treatment Diabetic Retinopathy Study, HRVO hemiretinal vein occlusion, RVO retinal vein occlusion, SBP systolic blood pressure